Intranasal Immunization: Promises and Challenges
Intranasal vaccines provide a convenient, easy-to-administer alternative to injectable drug delivery with potential to trigger mucosal immunity. This webinar provides an overview of intranasal vaccine formulations and the devices used to develop and manufacture nasal spray vaccines. The advantages and disadvantages of vaccination via the nose are discussed and views on the opportunities that intranasal immunization could offer are presented. Aptar Pharma’s nasal spray device portfolio includes platforms for single or double dose vaccine delivery and is backed by extensive expertise in formulation for nasal drug delivery. Collaboration with Aptar Pharma can therefore be an efficient strategy for bringing intranasal vaccines successfully to market and establishing the secure supply chains required to meet growing demand, following commercialization.
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Requesting access to Intranasal Immunization: Promises and Challenges.